This message was posted by a user wishing to remain anonymous
I was asked this question by a colleague but as someone deeply embedded in the Pharma World, I have no idea what the answer is.
With respect to
Shonin - Japan Device Submission Requirement: does the validation report [end-user testing outcome] need to be part of the Shonin submission? If needed, could the Shonin submission be amended with the validation report during review? What are the "must have" reports in a Shonin application and where are the submission requirements contents listed and are they in English?
Thanks in advance for any assistance. Just pointing me in the right direction would be helpful.